BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32199683)

  • 21. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.
    Barthélémy I; Pinto-Mariz F; Yada E; Desquilbet L; Savino W; Silva-Barbosa SD; Faussat AM; Mouly V; Voit T; Blot S; Butler-Browne G
    Dis Model Mech; 2014 Nov; 7(11):1253-61. PubMed ID: 25261568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.
    Barthélémy I; Uriarte A; Drougard C; Unterfinger Y; Thibaud JL; Blot S
    PLoS One; 2012; 7(11):e48478. PubMed ID: 23185260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS.
    Dabiré H; Barthélémy I; Blanchard-Gutton N; Sambin L; Sampedrano CC; Gouni V; Unterfinger Y; Aguilar P; Thibaud JL; Ghaleh B; Bizé A; Pouchelon JL; Blot S; Berdeaux A; Hittinger L; Chetboul V; Su JB
    Basic Res Cardiol; 2012 Jan; 107(1):240. PubMed ID: 22193759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN; Peterson JM; Bogan DJ; Kline W; Bogan JR; Dow JL; Fan Z; Wang J; Ahn M; Zhu H; Styner M; Guttridge DC
    Skelet Muscle; 2014; 4():18. PubMed ID: 25789154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.
    Kornegay JN; Spurney CF; Nghiem PP; Brinkmeyer-Langford CL; Hoffman EP; Nagaraju K
    ILAR J; 2014; 55(1):119-49. PubMed ID: 24936034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal carbohydrate metabolism in a canine model for muscular dystrophy.
    Amaral AR; Brunetto MA; Brólio MP; Cima DS; Miglino MA; Santos JPF; Ambrósio CE
    J Nutr Sci; 2017; 6():e57. PubMed ID: 29209496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
    Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
    PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.
    Wang J; Fan Z; Vandenborne K; Walter G; Shiloh-Malawsky Y; An H; Kornegay JN; Styner MA
    Int J Comput Assist Radiol Surg; 2013 Sep; 8(5):763-74. PubMed ID: 23299128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac structure and function in female carriers of a canine model of Duchenne muscular dystrophy.
    Kane AM; DeFrancesco TC; Boyle MC; Malarkey DE; Ritchey JW; Atkins CE; Cullen JM; Kornegay JN; Keene BW
    Res Vet Sci; 2013 Jun; 94(3):610-7. PubMed ID: 23231955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of cardiac progenitor cell potency in GRMD dogs.
    Cassano M; Berardi E; Crippa S; Toelen J; Barthelemy I; Micheletti R; Chuah M; Vandendriessche T; Debyser Z; Blot S; Sampaolesi M
    Cell Transplant; 2012; 21(9):1945-67. PubMed ID: 22513051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Grange RW
    Methods Mol Biol; 2011; 709():105-23. PubMed ID: 21194024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype.
    Stoughton WB; Li J; Balog-Alvarez C; Kornegay JN
    Muscle Nerve; 2018 Sep; 58(3):418-426. PubMed ID: 29513363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotyping lymphocyte and acute phase proteins in canine X-linked muscular dystrophy.
    Abreu DK; Monteiro JM; Souza CC; Karam RG; Fernandes RA; Lessa TB; Fagliari JJ; Miglino MA; Ambrosio CE
    An Acad Bras Cienc; 2018 Sep; 90(3):2977-2990. PubMed ID: 30304229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspected acute myocardial infarction in a dystrophin-deficient dog.
    Schneider SM; Coleman AE; Guo LJ; Tou S; Keene BW; Kornegay JN
    Neuromuscul Disord; 2016 Jun; 26(6):361-6. PubMed ID: 27105608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.
    Batra A; Barnard AM; Lott DJ; Willcocks RJ; Forbes SC; Chakraborty S; Daniels MJ; Arbogast J; Triplett W; Henricson EK; Dayan JG; Schmalfuss C; Sweeney L; Byrne BJ; McDonald CM; Vandenborne K; Walter GA
    BMC Cardiovasc Disord; 2022 Jun; 22(1):260. PubMed ID: 35681116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue Doppler assessment of diastolic and systolic alterations of radial and longitudinal left ventricular motions in Golden Retrievers during the preclinical phase of cardiomyopathy associated with muscular dystrophy.
    Chetboul V; Carlos C; Blot S; Thibaud JL; Escriou C; Tissier R; Retortillo JL; Pouchelon JL
    Am J Vet Res; 2004 Oct; 65(10):1335-41. PubMed ID: 15524319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.